Create a Report

Please provide report title
Please provide location
Please provide details

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by

Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Topotecan Injection 4 mg/4 mL (1 mg/mL) - recalled due to particulate matter, USA

2 years ago source www.fda.gov

Recall notice

United States

Company name: Teva Pharmaceuticals
Brand name: Teva
Product recalled: Topotecan Injection 4 mg/4 mL (1 mg/mL)
Reason of the recall: Presence of particulate matter
FDA Recall date: July 01, 2021
Recall details: Teva Pharmaceuticals has initiated a voluntary recall of lot 31328962B of Topotecan Injection 4 mg/4 mL (1 mg/mL), to the retail/institutional level in the United States. This voluntary recall was initiated based on a complaint received from a pharmacy after a single glass particle was observed inside one vial. After further examination of the complaint sample, two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

The administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material. If the particulate matter reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. While the health hazard risk could be severe if particulate matter is infused, Teva’s internal health assessment determined that the likelihood of patient exposure to impacted product is remote or unlikely.

To date, Teva has received no further complaints or reports of illness or injury.

- Carton NDC: 0703-4714. Vial NDC: 0703-4714-71. Lot# 31328962B. Exp. Date: 04/2022

Topotecan Injection, as a single agent, is indicated for the treatment of patients with metastatic ovarian cancer after disease progression on or after initial or subsequent chemotherapy and for patients with small cell lung cancer (SCLC) platinum-sensitive disease who progressed at least 60 days after initiation of first-line chemotherapy. It is also indicated for treatment of patients with Stage IV-B, recurrent, or persistent cervical cancer which is not amenable to curative treatment, in combination with cisplatin. It is packaged in 4 mg/4 mL single use vials. The affected product information is listed in the table above. Teva distributed the product nationwide to six of its Wholesale customers.

Teva notified its customers on June 18th 2021 and asked that the lot be recalled and to make arrangements for impacted product to be returned. Any consumer who has questions or concerns should first consult with their health care provider(s).

Check the full recall details on www.fda.gov

Source: FDA

#drugs #recall #blood #us

Recent Interesting Reports

Q

No Package, Durham, North Carolina, USA

1 week ago reported by user-qcchx737

I ordered clothes from an Instagram add almost a month ago. The “tracking” given shows limited information and according to the tracking website it was delivered however I have yet to receive the package. The website has no phone number only an email address. I got a … See More
response from service@ risktic. com the first time when I emailed them a day after the package was said to have been delivered and I was instructed to wait 48 hours. I waited then sent another email (the only source of communication) to the same address but this time no response. I sent another email asking for a complete refund, the prior email I only requested the dresses. The response from this email was a different address support@ lixvb. com and asked if they could refund 50%. This is a complete scam. Don’t buy from them. It’s been 30 day and still no dresses.

https: //risktic. com
See Less

#scam #onlineshopping #delivery #onlinescam #durham #northcarolina #us

J
I ordered from the company GRA very confused.
Ordered from a clothing company and instead of sending me clothes they sent me a Dimond ring? Looks very fake. The company name is GRA and on the card they sent it says they have a certificate but doesn’t … See More
look legit turns out this happend to heaps of others very concerned should I be worried?
See Less

#gramoissaniteringscam #scam #onlineshopping #onlinescam #delivery

Last 30 days